AI assistant
Sending…
TuHURA Biosciences, Inc./NV — Director's Dealing 2021
Mar 31, 2021
34026_dirs_2021-03-31_1b2e4dda-a1ee-44c3-9cf4-a7a92a7dd34e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Kintara Therapeutics, Inc. (KTRA)
CIK: 0001498382
Period of Report: 2021-03-31
Reporting Person: TOTH ROBERT JOSEPH JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-31 | Common Stock | J | 8 | — | Acquired | 1238 | Direct |
Footnotes
F1: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
More from TuHURA Biosciences, Inc./NV
Capital/Financing Update
2026
May 29
Interim / Quarterly Report
2026
May 15
Report Publication Announcement
2026
May 15
Capital/Financing Update
2026
Apr 22
Capital/Financing Update
2026
Apr 8
Regulatory Filings
2026
Apr 8
Earnings Release
2026
Apr 1
Director's Dealing
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 17